Charles Schwab’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.89M | Sell |
1,359,657
-44,167
| -3% | -$293K | ﹤0.01% | 2210 |
|
|
2025
Q4 | $11M | Sell |
1,403,824
-42,795
| -3% | -$337K | ﹤0.01% | 2088 |
|
|
2025
Q3 | $11.8M | Buy |
1,446,619
+879,081
| +155% | +$5.84M | ﹤0.01% | 2041 |
|
|
2025
Q2 | $2.65M | Buy |
567,538
+143,763
| +34% | +$659K | ﹤0.01% | 2587 |
|
|
2025
Q1 | $2.33M | Buy |
423,775
+20,903
| +5% | +$84.4K | ﹤0.01% | 2560 |
|
|
2024
Q4 | $1.37M | Sell |
402,872
-489
| -0.1% | -$1.57K | ﹤0.01% | 2801 |
|
|
2024
Q3 | $1.15M | Sell |
403,361
-1,221
| -0.3% | -$3.14K | ﹤0.01% | 2878 |
|
|
2024
Q2 | $910K | Buy |
404,582
+38,289
| +10% | +$77.2K | ﹤0.01% | 2973 |
|
|
2024
Q1 | $810K | Buy |
366,293
+1,911
| +0.5% | +$4.94K | ﹤0.01% | 2857 |
|
|
2023
Q4 | $856K | Sell |
364,382
-631
| -0.2% | -$1.17K | ﹤0.01% | 2887 |
|
|
2023
Q3 | $679K | Hold |
365,013
| – | – | ﹤0.01% | 2932 |
|
|
2023
Q2 | $956K | Sell |
365,013
-9,978
| -3% | -$25.4K | ﹤0.01% | 2789 |
|
|
2023
Q1 | $611K | Buy |
374,991
+26,754
| +8% | +$33.5K | ﹤0.01% | 2885 |
|
|
2022
Q4 | $463K | Buy |
348,237
+10,410
| +3% | +$14.7K | ﹤0.01% | 3024 |
|
|
2022
Q3 | $528K | Sell |
337,827
-563
| -0.2% | -$931 | ﹤0.01% | 2988 |
|
|
2022
Q2 | $522K | Buy |
338,390
+290,923
| +613% | +$614K | ﹤0.01% | 3061 |
|
|
2022
Q1 | $122K | Sell |
47,467
-19,543
| -29% | -$47.7K | ﹤0.01% | 3389 |
|
|
2021
Q4 | $197K | Buy |
67,010
+44,532
| +198% | +$96.2K | ﹤0.01% | 3364 |
|
|
2021
Q3 | $56K | Hold |
22,478
| – | – | ﹤0.01% | 3440 |
|
|
2021
Q2 | $92K | Sell |
22,478
-99,459
| -82% | -$380K | ﹤0.01% | 3301 |
|
|
2021
Q1 | $550K | Buy |
121,937
+4,064
| +3% | +$21.9K | ﹤0.01% | 3043 |
|
|
2020
Q4 | $580K | Buy |
117,873
+10,377
| +10% | +$51.9K | ﹤0.01% | 2938 |
|
|
2020
Q3 | $638K | Buy |
107,496
+14,950
| +16% | +$59.8K | ﹤0.01% | 2813 |
|
|
2020
Q2 | $247K | Buy |
92,546
+4,432
| +5% | +$15.4K | ﹤0.01% | 3128 |
|
|
2020
Q1 | $172K | Buy |
88,114
+20,531
| +30% | +$88.3K | ﹤0.01% | 3037 |
|
|
2019
Q4 | $477K | Hold |
67,583
| – | – | ﹤0.01% | 2830 |
|
|
2019
Q3 | $665K | Hold |
67,583
| – | – | ﹤0.01% | 2695 |
|
|
2019
Q2 | $774K | Buy |
67,583
+13,956
| +26% | +$147K | ﹤0.01% | 2660 |
|
|
2019
Q1 | $539K | Buy |
53,627
+39,136
| +270% | +$501K | ﹤0.01% | 2738 |
|
|
2018
Q4 | $247K | Hold |
14,491
| – | – | ﹤0.01% | 2987 |
|
|
2018
Q3 | $255K | Buy |
+14,491
| New | +$315K | ﹤0.01% | 3043 |
|
Other funds holding XERS
VCM
RA
N
VPM
